Gene targeting reveals a hierarchy of transcription factors regulating specification of lymphoid cell fates

Current Opinion in Immunology

Volumn 8, Issue 2, 1996, Pages 160-165

  Singh, Harinder ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

B LYMPHOCYTE; GENE EXPRESSION; GENE TARGETING; HEMATOPOIETIC STEM CELL; LYMPHOID CELL; REGULATOR GENE; SHORT SURVEY; STEM CELL; T LYMPHOCYTE;

EID: 0029993328     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80053-7     Document Type: Article

References (40)

1. Rolink A, Melchers F: Molecular and cellular origins of B lymphocyte diversity. Cell 1991, 66:1081-1094.
2. Godfrey D, Zlotnik A: Control points in early T-cell development. Immunol Today 1993, 14:547-553.
3. Hardy R, Carmack C, Shinton S, Kemp J, Hayakawa K: Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 1991, 173:1213-1225.
4. Pfeffer K, Mak T: Lymphocyte ontogeny and activation in gene targeted mutant mice. Annu Rev Immunol 1994, 12:367-411.
5. Klemsz M, McKercher S, Celada A, Van Beveren C, Maki R: The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 1990, 61:113-124.
6. Hromas R, Orazi A, Neiman R, Maki R, Van Beveran C, Moore J, Klemsz M: Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood 1993, 82:2998-3004.
7. Goebl M: The PU.1 transcription factor is the product of the putative oncogene Spi-1. Cell 1990, 61:1165-1166.
8. Moreau-Gachelin F, Tavitian A, Tambourin P: Spi-1 is a putative oncogene in virally induced murine erythroleukemias. Nature 1988, 331:277-280.
9. Nelsen B, Tian G, Erman B, Gregoire J, Maki R, Graves B, Sen R: Regulation of lymphoid-specific immunoglobulin μ heavy chain gene enhancer by ETS domain proteins. Science 1993, 261:82-86.
10. Pongubala J, Nagulapalli S, Klemsz M, McKercher S, Maki R, Atchison M: PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ3′ enhancer activity. Mol Cell Biol 1992, 12:368-378.
11. Eisenbeis C, Singh H, Storb U: PU.1 is a component of a multi-protein complex which binds an essential site in the murine immunoglobulin λ2-4 enhancer. Mol Cell Biol 1993, 13:6452-6461.
12. Hagman J, Grosschedl R: An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene. Proc Natl Acad Sci USA 1992, 89:8889-8893.
13. Feldhaus A, Mbangkollo D, Arvin K, Klug C, Singh H: BLyF, a novel cell-type- and stage-specific regulator of the B lymphocyte gene mb-1. Mol Cell Biol 1992, 12:1126-1133.
14. Shin M, Koshland M: Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element. Genes Dev 1993, 7:2006-2015.
15. Scott E, Simon M, Anastasi J, Singh H: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994, 265:1573-1577. PU.1 is shown to be required for the development of lymphoid and myeloid progenitors during hematopoiesis. PU.1 is not needed for the generation of erythrocyte progenitors and megakaryocytes. This study provides support for the existence of a multipotential lymphoid-myeloid precursor.
16. Cumano A, Paige C, Iscove N, Brady G: Bipotential precursors of B cells and macrophages in murine fetal liver. Nature 1992, 356:612-615.
17. Georgopoulos K, Bigby M, Wang J-H, Molnar A, Wu P, Winandy S, Sharpe A: The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994, 79:143-156. Mutation in the Ikaros gene results in a lymphoid-specific defect. B- and T-lymphoid progenitors, as well as natural killer cells, are eliminated by the mutation. Hematopoiesis exclusively generates erythroid and myeloid cells in mutant mice.
18. Georgopoulos K, Moore D, Derfler B: Ikaros: an early lymphoid restricted transcription factor, a putative mediator for T cell commitment. Science 1992, 258:808-812.
19. Murre C, McCaw P, Baltimore D: A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 1989, 56:777-783.
20. Murre C, Bain G, van Dijik M, Engel I, Furnari B, Massari M, Matthews J, Quong M, Rivera R, Stuiver M: Structure and function of helix-loop-helix proteins. Biochim Biophys Acta 1994, 1218:129-135.
21. Lassar A, Davis R, Wright W, Kadesch T, Murre C, Voronova A, Baltimore D, Weintraub H: Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 1991, 66:305-315.
22. Bain G, Gruenwald S, Murre C: E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins. Mol Cell Biol 1993, 13:3522-3529.
23. 1 RAG-1, mb-1, CD19 and λ5 transcripts.
24. H rearrangement. Heterozygous embryos contain about half the number of B cells as wild-type littermates suggesting levels of E2A proteins regulate B-cell numbers.
25. Grawunder U, Leu T, Schatz D, Werner A, Rolink A, Melchers F, Winkler T: Down-regulation of Rag1 and Rag2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 1995, 3:601-608.
26. Hagman J, Belanger C, Travis A, Turck C, Grosschedl R: Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression. Genes Dev 1993, 7:760-763.
27. Hagman J, Travis A, Grosschedl R: A novel lineage-specific nuclear factor regulates mb-1 gene transcription at the early stages of B cell differentiation. EMBO J 1991, 10:3409-3417.
28. ••].
29. Barberis A, Widenhorn K, Vitelli L, Busslinger M: A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev 1990, 4:849-859.
30. Adams B, Dorfler P, Aguzzi A, Kozmik Z, Urbanek P, Fogy I, Busslinger M: Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev 1992, 6:1589-1607.
31. Kozmik Z, Wang S, Dorfler P, Adams B, Busslinger M: The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol 1992, 12:2662-2672.
32. preB1 gene. Eur J Immunol 1992, 22:37-43.
33. Liao F, Giannini S, Birshtein B: A nuclear DNA-binding protein expressed during early stages of B cell differentiation interacts with diverse segments within and 3′ of the IgH chain gene cluster. J Immunol 1992, 148:2909-2917.
34. Urbanek P, Wang Z-Q, Fetka I, Wagner E, Busslinger M: Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 1994, 79:901-912. BSAP-deficient mice reveal a requirement for the transcription factor in midbrain patterning and B lymphopoiesis. Mutant mice fail to produce pre-B, B and plasma cells. Molecular analysis of the B-lineage block remains to be reported.
35. Brown G, Bunce CM, Howie AJ, Lord JM: Stochastic or ordered lineage commitment during hemopoiesis? Leukemia 1987, 1:150-153.
36. Dorshkind K: Transcriptional control points during lymphopoiesis. Cell 1994, 79:751-753.
37. Mucenski M, Mclain K, Kier A, Swerdlow S, Schreiner C, Miller T, Pietryga D, Scott W, Potter S: A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991, 65:677-689.
38. Palacios R, Samaridis J: Bone marrow clones representing an intermediate stage of development between hematopoietic stem cells and pro-T-lymphocyte or pro-B-lymphocyte progenitors. Blood 1993, 81:1222-1238.
39. Mombaerts P, Iacomini J, Johnson R, Herrup K, Tonegawa S, Papaioannou V: RAG-1 deficient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877.
40. Shinkai Y, Rathbun G, Lam K, Oltz E, Stewart V, Mendelson M, Charron J, Datta M, Young F, Stall A, Alt F: RAG-2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.